Cleared Traditional

RayStation 11.0 (K211867) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211867 · RaySearch Laboratories AB (PUBL) · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
84d
Days
Class 2
Risk

K211867 is an FDA 510(k) clearance for the RayStation 11.0. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by RaySearch Laboratories AB (PUBL) (Stockholm, SE). The FDA issued a Cleared decision on September 8, 2021 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all RaySearch Laboratories AB (PUBL) devices

Submission Details

510(k) Number K211867 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 2021
Decision Date September 08, 2021
Days to Decision 84 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 107d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 113
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K211867.
INT Contour
K212274 · Carina Medical, LLC · Apr 2022
MRCAT Head & Neck
K214081 · Philips OY · Apr 2022
3D Bolus Software Application, 3D Brachy Software Application, Patient-Matched 3D Printed Radiation Therapy Accessory
K213438 · Adaptiiv · Jan 2022
AI Segmentation
K211881 · Varian Medical Systems, Inc. · Sep 2021
syngo.via RT Image Suite
K211379 · Siemens Medical Solutions USA, Inc. · Jul 2021
decimal Bolus
K211511 · .Decimal, LLC · Jul 2021